Peptidomimetic compounds and antibody-drug conjugates thereof
US10124069B2 · kind B2 · utility
1Cited by
6References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 2016 |
| Grant date | Nov 13, 2018 |
| Priority date | — |
| Expiry date | Jun 14, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to peptidomimetic linkers and anti-body drug conjugates thereof, to pharmaceutical compositions containing them, and to their use in therapy for the prevention or treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.